Spinal dural arte riovenous shunts (SDAVS) represent a specific and peculiar type of arteriovenous shunt, which went unrecognized until their first description be Kendall and Logue in 1977. The location of the shunt is dura l. being usually found on the dural sleeve of the nerve root of on the lateral surface of the dura covering the spinal cord. The shunt is beeing fed by one or several slightly dilated meningeal branches of a radicular artery and draining into a radicular vein which joins the perimedullary venous system of the spinal cord.
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SDAVS are aquired lesions most commoly occuring in male patients in their 5th decade. They produce a slowly progressive neurologic symptomatology characterized initially by progressive paresis. back andlor root pain, impotence, bladder and bowel disturb ance. With disease progression the most common symptom at the time of diagnosis paresis is occuring in 88% of cases. followed by bladder disturbance in 85% of cases. by bowel disturbance in 75% of cases. impotence in 43% and back andlor root pain in 37% of cases. The most common location of the shunt is at the lower thoracic or lumbar dura. It may also be located at the sacral level or at the upper-mid thoracic level. SDAVS have not been observed in the upper thoracic and cervical area. Exeptionally, cranial dural AVMs located at the level of the foramen magnum or on the tentorium may drain secondarily into the spinal cord veins and may thus lead to a spinal cord symptomatology similar to that produced by SDAVS. Rarely SDAVS may be multiple and coex-
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ist at different levels of the spinal cord. Clinically, the main difference between intracranial du ral AVMs and SDAVS is that the later never bleed. This is explaned by differences in the anatomy and physiology of the venous systems involved.
The clinical symptomatology of SDAVS is caused by venous engorgement in the perimedullary venous system leading to venous stasis at the intramedullary level. This is followed by intramedullary edema formation, which may progress to gliosis.and finally to Foix-Alajouanine syndrome.
Myelography is the method of choice for the initial evaluation of patients suspected clinically to have a SDAVS. However, recent advances in MR imaging and MR angiography now allow for accurate detection and definition of SDAVS in the majority of cases. In addition MRI detects any intramedullary edema or gliosis. thus prividing essential information on the extent of spinal cord dammage caused by the arteriovenous shunt. However. a negative MRI and MRA does not exclude the presence of a SDAVS and angiography is required in every case suspected clinically.
In the Institute of Neur oradiology of the University of Zur ich angiography is being performed in one session with the embolization treatment of SDAVS and under general anesthesia. The angiegraphic work up consist of a selective spinal panangiography with attention directed towards the venous drainage of the spinal cord. If there is evidence of abnormal venous drainage. then the fistula location is sought. If a norm al veno us phase is visualized, the vessels demonstrated should correspond exactly to the defects dem onstrated on myelography or on the vascular structures see n on MR angiography. If this is the case. then the angiegraphic explora tion is considered normal and the procedu re is discon tinued. When a SDAVS is found angiogra phically, then magnified angiegra phic views are pe rformed to demonstr ate the intrinsic architecture of the lesion and any association with a radiculo-medull ary or radiculo-pial ar tery. With the use of road mappin g, superse lective cath eterisation of the fistula is the n performed with an appropriate microcatheter over a microguidewire. Embolization is being always perform ed with NBCA mixed approp riately with Lipiodol. The mixture of NBCA and Lipiodo l is deposited in the fistula itself as well as in the first millimete rs of the drain ing rad icular vein. Passage of NBCA in to the perimedullary veins should be avoided as well as early polymerisation of NBCA witho ut reaching the radicular vein.
In the author's expe rience the clinical outcome depends primarily on the duration of the disease prior to treatment. If the disease lasted for less than twelve months the clinical outcome is usually excellent or satisfactory. If the disease lasted for more than twelve mon ths no satisfacto ry neurologic improvement is seen, despite complete and correct exclusion of the lesion beca use of the irreversible spinal cord dammage caused by the chron ic venous congestion. In some cases postoper ative det erioration has been observed. It seems that this det erioration is primarily related to secondary thrombosis of perimedullary veins. Embolisation is contraindicated if a rad iculomedullary of a radicul opial artery arises at the same level as the pathologic feedin g dur al artery and superse lective catheterisation of the fistula distal to the origin of the se art eries is not poss ible.
Absence of clinical improvement following a compl et e and correc t em bolisation in a patient with a disease lasting for less than twelve months should prompt re pea t angiography for detection of a second SDAVS. 
